Genentech announces results from pertuzumab studies on HER2-positive breast cancer

		Cancer Friends Network > Types of Cancer > Anal cancer
Genentech announces results from pertuzumab studies on HER2-positive breast cancer

LinkBack

Thread Tools

Display Modes

#1 (permalink)

12-28-2011, 03:33 PM

cancerfr

Administrator

Join Date: Sep 2008

Posts: 47,256

Genentech announces results from pertuzumab studies on HER2-positive breast cancer

Genentech, a member of the Roche Group, today announced the company will present results from studies of its investigational medicine pertuzumab in HER2-positive breast cancer at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium December 6-10.

Tim Pearson

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On Forum Rules

All times are GMT. The time now is 10:57 PM.

CancerFriends.net